Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.

@article{Lacave1983PhaseIC,
  title={Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.},
  author={Angel Jim{\'e}nez Lacave and I. Izarzugaza and Luis Miguel Ant{\'o}n Aparicio and M Valle Pereda and J M Gracia Marco and Jos{\'e} Mar{\'i}a Buesa},
  journal={American journal of clinical oncology},
  year={1983},
  volume={6 1},
  pages={35-8}
}
Eighteen patients with gastric cancer in Stage IV who had failed combination chemotherapy were treated with cis-dichlorodiammineplatinum as a single agent. Objective response was observed in four patients (22%), and another two had stable disease lasting 114 and 234 days, respectively. The median duration of the response was 150 days (range, 92-186… CONTINUE READING